Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
62.3M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
39.3M
-
Shares change
-
-183K
-
Total reported value, excl. options
-
$230M
-
Value change
-
-$11.9M
-
Put/Call ratio
-
1.07
-
Number of buys
-
40
-
Number of sells
-
-43
-
Price
-
$5.86
Significant Holders of Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share (AURA) as of Q1 2025
108 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2025.
Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share (AURA) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.3M shares
of 62.3M outstanding shares and own 63.05% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (6.92M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.88M shares), BlackRock, Inc. (3.54M shares), Long Focus Capital Management, LLC (3.32M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.73M shares), FRANKLIN RESOURCES INC (2.21M shares), VANGUARD GROUP INC (1.95M shares), LEVIN CAPITAL STRATEGIES, L.P. (1.36M shares), and Nantahala Capital Management, LLC (1.27M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.